Dr. Arunava Roy Reviews

A 28-year-old tribal woman from Wayanad presented with advanced cervical cancer after avoiding care due to cultural stigma. Dr. Roy arranged for community health workers to provide education and transportation support. He performed radical hysterectomy with pelvic lymph node dissection, followed by tailored chemoradiation. The patient became a community health advocate after full recovery.

A 45-year-old corporate executive discovered stage I ovarian cancer during fertility preservation consultation. Dr. Roy performed fertility-sparing surgery with unilateral oophorectomy and meticulous staging. She conceived via IVF one year post-treatment and delivered a healthy baby at term while remaining cancer-free.

An 82-year-old nun from a local convent presented with recurrent endometrial cancer after previous treatment elsewhere. Dr. Roy developed a palliative care plan focusing on quality of life, using minimally invasive procedures for symptom management. The patient maintained her daily routines throughout treatment until peaceful passing 18 months later.

A 19-year-old college student with Turner syndrome developed rare dysgerminoma. Dr. Roy coordinated with pediatric endocrinologists to preserve hormonal function while performing conservative surgery. The patient completed chemotherapy and maintained ovarian function with hormone replacement therapy.

A 35-year-old ******* man (female-to-male) presented with abnormal bleeding while on testosterone therapy. Dr. Roy provided gender-affirming care while diagnosing early-stage endometrial cancer. He performed hysterectomy with bilateral salpingo-oophorectomy using minimally invasive techniques, respecting the patient's gender identity throughout treatment.

A 52-year-old fisherwoman from coastal Kerala presented with advanced vulvar cancer complicated by chronic seawater exposure dermatitis. Dr. Roy collaborated with dermatologists to manage skin conditions before performing radical vulvectomy with reconstructive surgery using novel tissue grafting techniques.

A 41-year-old woman with untreated HIV presented with rapidly progressive cervical cancer. Dr. Roy worked with infectious disease specialists to optimize antiretroviral therapy before performing chemoradiation. The patient achieved complete response and maintained undetectable viral load post-treatment.

A 63-year-old retired schoolteacher developed uterine sarcoma with rare genetic markers. Dr. Roy arranged for comprehensive genomic testing and secured access to targeted therapy through clinical trials. The patient experienced significant tumor regression with minimal side effects from precision medicine approach.

A 31-year-old woman with cerebral palsy and severe scoliosis presented with complex ovarian masses. Dr. Roy adapted surgical positioning and anesthesia approach to accommodate physical limitations. The multidisciplinary team successfully removed benign teratomas while managing her complex musculoskeletal needs.

A 47-year-old breast cancer survivor developed metastatic ovarian cancer 10 years after initial treatment. Dr. Roy identified BRCA mutation and used PARP inhibitor therapy alongside cytoreductive surgery. The patient achieved prolonged remission while participating in genetic counseling for her daughters.

A 58-year-old woman with morbid obesity and multiple comorbidities presented with endometrial cancer. Dr. Roy employed enhanced recovery after surgery protocols and coordinated with bariatric specialists for pre-operative optimization. Robotic-assisted surgery allowed successful treatment with reduced complication risk.

A 24-year-old professional athlete discovered early cervical cancer during routine screening. Dr. Roy performed radical trachelectomy, preserving fertility and pelvic floor function. The patient returned to competitive sports within 6 months and conceived naturally two years later.

A 70-year-old woman with dementia presented with advanced ovarian cancer. Dr. Roy worked closely with family caregivers and geriatric specialists to create a simplified treatment plan. The patient tolerated dose-modified chemotherapy well and maintained good quality of life with family support.